PMID: 16518475Mar 7, 2006Paper

Evaluation of progression-free interval in patients with ovarian cancer treated by first-line chemotherapy with paclitaxel and carboplatin

Magyar onkologia
O Lehoczky, T Pulay

Abstract

Combination therapy with paclitaxel is widely proposed for first-line adjuvant treatment in ovarian cancer patients in Hungary as well as worldwide. The authors summarize the results of paclitaxel-carboplatin therapy of the years from 2000 to 2002, and compare them to the results observed in 2002. 86 patients with ovarian cancer of stage I-IV were treated with the combination with paclitaxel (175 mg/m2, 3 hours) and carboplatin (AUC 5) at the Gynecological Department, National Institute of Oncology, Budapest. Average age of the patients was found 54+/-9.8 years. Optimal surgery (hysterectomy with bilateral adnexectomy and omentectomy with a maximal residual tumor burden of 1 cm) was done in 43 of the 86 patients. Tumor-free status was found in 60% and 31% of the patients in 2002 and 2005 respectively. Tumor-free status was observed in the groups of optimally operated and non-optimally operated patients in 79% and 42% in 2002 and in 44% and 19% in 2005. Median progression-free interval was higher in the optimally than in the nonoptimally operated patients (25 and 11 months), and was resulted in 16.5 months of all patients. Our paclitaxel-carboplatin treatment resulted in a similar progression-free interval as that was found in t...Continue Reading

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.